Theoretical perspectives and clinical applications of non-coding RNA in lung cancer metastasis: a systematic review
- PMID: 39937377
- PMCID: PMC11822152
- DOI: 10.1007/s12672-025-01919-3
Theoretical perspectives and clinical applications of non-coding RNA in lung cancer metastasis: a systematic review
Abstract
Lung cancer is one of the deadliest malignancies worldwide, with distant metastasis being a major cause of death. However, the specific mechanisms of lung cancer metastasis remain unclear. NcRNAs, a widely present type of non-coding RNAs in the body, constitute about 98% of the human genome, lacking protein-coding capacity but involved in various cellular processes such as proliferation, apoptosis, invasion, and migration. Studies have shown that ncRNAs play a crucial role in the metastasis of lung cancer, although research in this area is limited. This review summarizes the biological origins and functions of ncRNAs, their specific roles and mechanisms in lung cancer metastasis, and discusses their potential for early screening and therapeutic applications in lung cancer. Furthermore, it outlines the challenges in translating basic advancements of ncRNAs in lung cancer metastasis into clinical practice.
Keywords: Circular RNA; Long non-coding RNA; Lung cancer; Metastasis; MicroRNA; Non-coding RNA.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: No ethics approval was required for this review that did not involve patients or patient data. Consent for publication: All authors consent to publication. Competing interests: The authors declare no competing interests.
Figures


Similar articles
-
The significance of exosomal non-coding RNAs (ncRNAs) in the metastasis of colorectal cancer and development of therapy resistance.Gene. 2025 Feb 10;937:149141. doi: 10.1016/j.gene.2024.149141. Epub 2024 Dec 4. Gene. 2025. PMID: 39643147 Review.
-
Non-coding RNAs and glioblastoma: Insight into their roles in metastasis.Mol Ther Oncolytics. 2021 Dec 22;24:262-287. doi: 10.1016/j.omto.2021.12.015. eCollection 2022 Mar 17. Mol Ther Oncolytics. 2021. PMID: 35071748 Free PMC article. Review.
-
Non-Coding RNA as a Biomarker in Lung Cancer.Noncoding RNA. 2024 Sep 30;10(5):50. doi: 10.3390/ncrna10050050. Noncoding RNA. 2024. PMID: 39452836 Free PMC article. Review.
-
Non-coding RNA dysregulation in skin cancers.Essays Biochem. 2021 Oct 27;65(4):641-655. doi: 10.1042/EBC20200048. Essays Biochem. 2021. PMID: 34414406
-
Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications.Front Oncol. 2023 Sep 8;13:1256537. doi: 10.3389/fonc.2023.1256537. eCollection 2023. Front Oncol. 2023. PMID: 37746261 Free PMC article. Review.
References
-
- Chen K, He Y, Wang W, Yuan X, Carbone DP, Yang F. Development of new techniques and clinical applications of liquid biopsy in lung cancer management. Sci Bull. 2024;69:1556–68. - PubMed
-
- Li Y, Yan B, He S. Advances and challenges in the treatment of lung cancer. Biomed Pharmacother. 2023;169: 115891. - PubMed
-
- Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet. 2021;398:535–54. - PubMed
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34. - PubMed
-
- Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144:1941–53. - PubMed
Publication types
LinkOut - more resources
Full Text Sources